首页 > 最新文献

Annals of vascular diseases最新文献

英文 中文
Clinical Results 5 Years after Radiofrequency Ablation of Saphenous Veins. 临床结果:射频消融隐静脉后5年。
IF 0.6 Q4 PERIPHERAL VASCULAR DISEASE Pub Date : 2025-01-01 Epub Date: 2025-09-11 DOI: 10.3400/avd.oa.25-00097
Hitoshi Kusagawa

Objectives: In Japan, radiofrequency ablation (RFA) was covered by insurance in 2014. Regarding the early results, there are many reports that it is excellent, but the long-term results are rarely shown. Therefore, the purpose of this study was to examine the results up to 5 years after RFA, which was the only means of endovascular treatment at my facility, and to evaluate recurrent varices after surgery (REVAS), reoperation, and complications.

Methods: In 2017, 275 consecutive cases (male 83, female 192, 67.5 ± 10.0 years old), involving 350 limbs (C2, 3, 4a, 4b, 5, 6 = 217, 18, 89, 18, 1, 7) and 354 veins (great saphenous vein [GSV]: 290, small saphenous vein [SSV]: 64), underwent RFA. Postoperative follow-up was usually performed at 3 days (100%), 1 week (100%), 1 month (99.4%), and 6 months (93.5%) after RFA. Of the 334 patients contacted 5 years later, 327 (92.4%), excluding deaths from other diseases, were interviewed about reoperation, recurrence, and neuropathy. Of these, 223 patients (63%, GSV: 180, SSV: 43) underwent an ultrasound examination.

Results: Endovenous heat-induced thrombosis (EHIT) of more than grade 2 occurred in 5.9% of cases (GSV: 6.6%, SSV: 3.1%) and regressed within 1 month in all cases using anticoagulant therapy. Neuropathy occurred in 6.3%, mainly in GSV full-length ablation cases, and 41% of these disappeared completely between 6 months and 5 years after RFA. The reoperation rate up to 5 years after RFA was 10.7% (GSV: 9.7, SSV: 15.6%). In the reoperation cases after the RFA of GSV, the sites of reflux were 14 incompetent perforating veins (IPVs), 7 deep venous junction-related, and 6 distal GSVs. In the reoperation cases after the RFA of SSV, there were 5 IPVs and 3 isolated branch varices. The time of diagnosis of recurrence by ultrasonography was within 6 months of regular follow-up in 61% of GSVs and 79% of SSVs. The occlusion rate after 5 years was 98.9% for GSV and 95.3% for SSV. Only 1 recanalized vein was symptomatic and underwent retreatment. After RFA of GSV, 80% of accessory saphenous veins were retained at 5 years.

Conclusions: 1) The 5-year results after RFA were generally good. 2) IPV played the most important role in reoperation cases by REVAS after RFA of the saphenous veins. 3) The majority of postoperative recurrences could be identified by follow-up up to 6 months. 4) Neuropathy after RFA disappeared completely in half of the cases within 5 years. 5) After GSV-RFA, accessory saphenous vein blood flow persisted in most cases. (This is a translation of Jpn J Phlebol 2024; 35: 403-408.).

目的:在日本,射频消融(RFA)在2014年被纳入保险。关于早期的结果,有很多报道说它是优秀的,但很少有长期的结果显示。因此,本研究的目的是检查RFA后5年的结果,RFA是我的医院血管内治疗的唯一手段,并评估手术后静脉曲张复发(REVAS)、再手术和并发症。方法:2017年,连续275例患者(男性83例,女性192例,年龄67.5±10.0岁)行RFA,涉及350个肢体(C2、3、4a、4b、5、6 = 217、18、89、18、1、7)和354条静脉(大隐静脉[GSV]: 290条,小隐静脉[SSV]: 64条)。术后随访时间分别为RFA后3天(100%)、1周(100%)、1个月(99.4%)和6个月(93.5%)。5年后随访的334例患者中,除其他疾病死亡外,327例(92.4%)接受了关于再手术、复发和神经病变的访谈。其中223例(63%,GSV: 180, SSV: 43)接受了超声检查。结果:静脉内热致血栓(EHIT) 2级以上发生率为5.9% (GSV: 6.6%, SSV: 3.1%),所有使用抗凝治疗的病例均在1个月内消退。神经病变发生率为6.3%,主要发生在GSV全长消融病例中,其中41%在RFA后6个月至5年内完全消失。术后5年再手术率为10.7% (GSV: 9.7, SSV: 15.6%)。在GSV RFA后再手术病例中,返流部位为14条无功能穿通静脉(IPVs), 7条深静脉连接相关静脉,6条远端GSV。SSV射频消融后再手术病例中,有5个IPVs和3个孤立支静脉曲张。超声诊断复发的时间在常规随访6个月内,61%的GSVs和79%的ssv。5年后GSV的闭塞率为98.9%,SSV为95.3%。只有1条再通静脉出现症状并接受了再治疗。GSV RFA术后5年副隐静脉保留率达80%。结论:1)RFA术后5年疗效总体良好。2)隐静脉射频消融术后再行REVAS手术的病例中,IPV的作用最为重要。3)大部分术后复发可通过随访6个月确定。4)半数RFA后神经病变在5年内完全消失。5) GSV-RFA术后副隐静脉血流持续。(这是Jpn J Phlebol 2024; 35: 403-408的翻译)。
{"title":"Clinical Results 5 Years after Radiofrequency Ablation of Saphenous Veins.","authors":"Hitoshi Kusagawa","doi":"10.3400/avd.oa.25-00097","DOIUrl":"10.3400/avd.oa.25-00097","url":null,"abstract":"<p><strong>Objectives: </strong>In Japan, radiofrequency ablation (RFA) was covered by insurance in 2014. Regarding the early results, there are many reports that it is excellent, but the long-term results are rarely shown. Therefore, the purpose of this study was to examine the results up to 5 years after RFA, which was the only means of endovascular treatment at my facility, and to evaluate recurrent varices after surgery (REVAS), reoperation, and complications.</p><p><strong>Methods: </strong>In 2017, 275 consecutive cases (male 83, female 192, 67.5 ± 10.0 years old), involving 350 limbs (C2, 3, 4a, 4b, 5, 6 = 217, 18, 89, 18, 1, 7) and 354 veins (great saphenous vein [GSV]: 290, small saphenous vein [SSV]: 64), underwent RFA. Postoperative follow-up was usually performed at 3 days (100%), 1 week (100%), 1 month (99.4%), and 6 months (93.5%) after RFA. Of the 334 patients contacted 5 years later, 327 (92.4%), excluding deaths from other diseases, were interviewed about reoperation, recurrence, and neuropathy. Of these, 223 patients (63%, GSV: 180, SSV: 43) underwent an ultrasound examination.</p><p><strong>Results: </strong>Endovenous heat-induced thrombosis (EHIT) of more than grade 2 occurred in 5.9% of cases (GSV: 6.6%, SSV: 3.1%) and regressed within 1 month in all cases using anticoagulant therapy. Neuropathy occurred in 6.3%, mainly in GSV full-length ablation cases, and 41% of these disappeared completely between 6 months and 5 years after RFA. The reoperation rate up to 5 years after RFA was 10.7% (GSV: 9.7, SSV: 15.6%). In the reoperation cases after the RFA of GSV, the sites of reflux were 14 incompetent perforating veins (IPVs), 7 deep venous junction-related, and 6 distal GSVs. In the reoperation cases after the RFA of SSV, there were 5 IPVs and 3 isolated branch varices. The time of diagnosis of recurrence by ultrasonography was within 6 months of regular follow-up in 61% of GSVs and 79% of SSVs. The occlusion rate after 5 years was 98.9% for GSV and 95.3% for SSV. Only 1 recanalized vein was symptomatic and underwent retreatment. After RFA of GSV, 80% of accessory saphenous veins were retained at 5 years.</p><p><strong>Conclusions: </strong>1) The 5-year results after RFA were generally good. 2) IPV played the most important role in reoperation cases by REVAS after RFA of the saphenous veins. 3) The majority of postoperative recurrences could be identified by follow-up up to 6 months. 4) Neuropathy after RFA disappeared completely in half of the cases within 5 years. 5) After GSV-RFA, accessory saphenous vein blood flow persisted in most cases. (This is a translation of Jpn J Phlebol 2024; 35: 403-408.).</p>","PeriodicalId":7995,"journal":{"name":"Annals of vascular diseases","volume":"18 1","pages":""},"PeriodicalIF":0.6,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12436687/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145079481","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Three Cases of Stent-Assisted Balloon-Induced Intimal Disruption and Relamination in Aortic Dissection Repair Effectively Treating Chronic Type B Aortic Dissection with False Lumen Aneurysm. 支架辅助球囊破裂主动脉夹层修复术3例有效治疗慢性B型主动脉夹层伴假腔动脉瘤。
IF 0.6 Q4 PERIPHERAL VASCULAR DISEASE Pub Date : 2025-01-01 Epub Date: 2025-09-20 DOI: 10.3400/avd.cr.25-00046
Kanako Kobayashi, Naoki Fujimura, Ayaka Yu, Kyosuke Hosokawa, Yujiro Kawai, Takahito Itoh, Takahiro Shoji, Hirohisa Harada

Successful thoracic endovascular aortic repair for chronic type B aortic dissection with an enlarged false lumen depends on complete exclusion of the false lumen. Stent-assisted balloon-induced intimal disruption and relamination in aortic dissection repair (STABILISE) creates a single lumen in the dissected thoracic and abdominal aorta by disrupting the intima. We report our experience in the treatment of 3 cases of chronic dissection using the STABILISE procedure at our hospital from December 2019 to May 2022. The STABILISE technique appears to be an effective procedure; however, further evaluation of risk factors for complications such as intraoperative aortic rupture is necessary.

慢性B型主动脉夹层伴假腔增大的胸主动脉腔内修复术的成功与否取决于假腔的完全排除。在主动脉夹层修复中,支架辅助球囊诱导的内膜破裂和再层压(稳定)通过破坏内膜在剥离的胸主动脉和腹主动脉中形成一个单一的管腔。我们报告了2019年12月至2022年5月在我院使用稳定手术治疗3例慢性夹层的经验。稳定技术似乎是一个有效的程序;然而,进一步评估术中主动脉破裂等并发症的危险因素是必要的。
{"title":"Three Cases of Stent-Assisted Balloon-Induced Intimal Disruption and Relamination in Aortic Dissection Repair Effectively Treating Chronic Type B Aortic Dissection with False Lumen Aneurysm.","authors":"Kanako Kobayashi, Naoki Fujimura, Ayaka Yu, Kyosuke Hosokawa, Yujiro Kawai, Takahito Itoh, Takahiro Shoji, Hirohisa Harada","doi":"10.3400/avd.cr.25-00046","DOIUrl":"10.3400/avd.cr.25-00046","url":null,"abstract":"<p><p>Successful thoracic endovascular aortic repair for chronic type B aortic dissection with an enlarged false lumen depends on complete exclusion of the false lumen. Stent-assisted balloon-induced intimal disruption and relamination in aortic dissection repair (STABILISE) creates a single lumen in the dissected thoracic and abdominal aorta by disrupting the intima. We report our experience in the treatment of 3 cases of chronic dissection using the STABILISE procedure at our hospital from December 2019 to May 2022. The STABILISE technique appears to be an effective procedure; however, further evaluation of risk factors for complications such as intraoperative aortic rupture is necessary.</p>","PeriodicalId":7995,"journal":{"name":"Annals of vascular diseases","volume":"18 1","pages":""},"PeriodicalIF":0.6,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12460030/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145147541","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Short and Mid-term Outcome of Radiofrequency Ablation without Concomitant Phlebectomy/Sclerotherapy for Tributary Varicose Veins. 无静脉切除术/硬化治疗的静脉曲张的射频消融的短期和中期结果。
IF 0.6 Q4 PERIPHERAL VASCULAR DISEASE Pub Date : 2025-01-01 Epub Date: 2025-01-08 DOI: 10.3400/avd.oa.24-00130
Toshihiro Kawahira, Fumihiro Miyashita, Eiji Hitomi, Masahide Enomoto, Yasuo Kondo, Masanori Morimoto, Naoshi Minamidate, Noriyuki Takashima, Tomoaki Suzuki

Endovenous surgery in the treatment of varicose veins generally consists of laser or radiofrequency ablation (RFA) as endovenous thermal ablation (ETA) with a phlebectomy or foam sclerotherapy of tributary varicose veins to improve symptomatic or cosmetic problems. Nevertheless, the efficacy of their concomitant treatments is still controversial for a decade. In the guidelines of the Japanese Society of Phlebology, concomitant phlebectomy of tributary varicose veins with ETA is described that it is not recommended officially. In our hospital, RFA without concomitant phlebectomy of tributary varicose veins accounts for 74% of the RFA cases and it shows a relatively higher percentage than other institutions in Japan. The data of RFA without concomitant phlebectomy of tributary varicose veins are evenly matched in RFA with concomitant treatments in our data concerning recurrence, remnants, endovenous heat-induced thrombosis (EHIT), and complications. This article provides the conclusion that it would be acceptable to perform isolated RFA compared to RFA with concomitant phlebectomy or foam sclerotherapy of tributary varicose veins in short- and mid-term periods. In addition, concomitant treatments might contribute to rapid improvement of the short-term and better long-term outcomes, not to mention cosmetic problems that are not identified demonstrably. (This is a translation of J Jpn Coll Angiol 2022; 62: 49-54.).

静脉内手术治疗静脉曲张通常包括激光或射频消融(RFA)作为静脉内热消融(ETA)与静脉切除术或泡沫硬化治疗分支静脉曲张,以改善症状或美容问题。然而,十年来,他们的伴随治疗的有效性仍然存在争议。在日本静脉学会的指导方针中,ETA伴行静脉曲张的静脉切除术是不被正式推荐的。在我院,不合并支静脉曲张的RFA占RFA病例的74%,比日本其他机构的比例要高。在我们关于复发、残留、静脉内热致血栓形成(EHIT)和并发症的数据中,不同时行支静脉曲张静脉切除术的RFA数据与同时治疗的RFA数据相当。本文的结论是,与RFA合并静脉切除术或泡沫硬化治疗短中期静脉曲张相比,单独进行RFA是可以接受的。此外,伴随治疗可能有助于快速改善短期和更好的长期结果,更不用说没有明确识别的美容问题。(这是j.jpn Coll angol 2022的翻译;62: 49-54)。
{"title":"Short and Mid-term Outcome of Radiofrequency Ablation without Concomitant Phlebectomy/Sclerotherapy for Tributary Varicose Veins.","authors":"Toshihiro Kawahira, Fumihiro Miyashita, Eiji Hitomi, Masahide Enomoto, Yasuo Kondo, Masanori Morimoto, Naoshi Minamidate, Noriyuki Takashima, Tomoaki Suzuki","doi":"10.3400/avd.oa.24-00130","DOIUrl":"10.3400/avd.oa.24-00130","url":null,"abstract":"<p><p>Endovenous surgery in the treatment of varicose veins generally consists of laser or radiofrequency ablation (RFA) as endovenous thermal ablation (ETA) with a phlebectomy or foam sclerotherapy of tributary varicose veins to improve symptomatic or cosmetic problems. Nevertheless, the efficacy of their concomitant treatments is still controversial for a decade. In the guidelines of the Japanese Society of Phlebology, concomitant phlebectomy of tributary varicose veins with ETA is described that it is not recommended officially. In our hospital, RFA without concomitant phlebectomy of tributary varicose veins accounts for 74% of the RFA cases and it shows a relatively higher percentage than other institutions in Japan. The data of RFA without concomitant phlebectomy of tributary varicose veins are evenly matched in RFA with concomitant treatments in our data concerning recurrence, remnants, endovenous heat-induced thrombosis (EHIT), and complications. This article provides the conclusion that it would be acceptable to perform isolated RFA compared to RFA with concomitant phlebectomy or foam sclerotherapy of tributary varicose veins in short- and mid-term periods. In addition, concomitant treatments might contribute to rapid improvement of the short-term and better long-term outcomes, not to mention cosmetic problems that are not identified demonstrably. (This is a translation of J Jpn Coll Angiol 2022; 62: 49-54.).</p>","PeriodicalId":7995,"journal":{"name":"Annals of vascular diseases","volume":"18 1","pages":""},"PeriodicalIF":0.6,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11771147/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143057716","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mechanical Evaluation of Stenting for Saccular Abdominal Aortic Aneurysm Using Fluid Structure Interaction Analysis. 应用流体结构相互作用分析评价囊性腹主动脉瘤支架植入术的力学性能。
IF 0.6 Q4 PERIPHERAL VASCULAR DISEASE Pub Date : 2025-01-01 Epub Date: 2025-02-20 DOI: 10.3400/avd.oa.24-00131
Masanori Murakami, Fei Jiang, Shahreen Bin Saiful Yew, Xian Chen

One of the factors that contribute to the development of aortic aneurysms is hemodynamic factors. In this study, we analyzed the hemodynamic changes in a stented saccular abdominal aortic aneurysm model to improve hemodynamic factors. We discovered that stenting reduced wall shear stress, mean flow velocity in the aneurysm, energy loss, and pressure loss coefficient, and improved hemodynamics around the saccular abdominal aortic aneurysm. Stenting is expected to become a new treatment modality for abdominal aortic aneurysms. (This is a translation of J Jpn Coll Angiol 2022; 62: 111-119.).

导致主动脉瘤发生的因素之一是血流动力学因素。在本研究中,我们分析了支架状囊性腹主动脉瘤模型的血流动力学变化,以改善血流动力学因素。我们发现支架植入降低了壁面剪切应力、动脉瘤内平均流速、能量损失和压力损失系数,并改善了囊状腹主动脉瘤周围的血流动力学。支架置入术有望成为腹主动脉瘤的一种新的治疗方式。(这是j.jpn Coll angol 2022的翻译;62: 111 - 119)。
{"title":"Mechanical Evaluation of Stenting for Saccular Abdominal Aortic Aneurysm Using Fluid Structure Interaction Analysis.","authors":"Masanori Murakami, Fei Jiang, Shahreen Bin Saiful Yew, Xian Chen","doi":"10.3400/avd.oa.24-00131","DOIUrl":"10.3400/avd.oa.24-00131","url":null,"abstract":"<p><p>One of the factors that contribute to the development of aortic aneurysms is hemodynamic factors. In this study, we analyzed the hemodynamic changes in a stented saccular abdominal aortic aneurysm model to improve hemodynamic factors. We discovered that stenting reduced wall shear stress, mean flow velocity in the aneurysm, energy loss, and pressure loss coefficient, and improved hemodynamics around the saccular abdominal aortic aneurysm. Stenting is expected to become a new treatment modality for abdominal aortic aneurysms. (This is a translation of J Jpn Coll Angiol 2022; 62: 111-119.).</p>","PeriodicalId":7995,"journal":{"name":"Annals of vascular diseases","volume":"18 1","pages":""},"PeriodicalIF":0.6,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11858217/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143498057","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Retrospective Study of 43 Cases of Visceral Artery Aneurysms: Evaluation of Surgical Indications Based on the 2020 Revised Guidelines of the Society for Vascular Surgery. 43例内脏动脉瘤的回顾性研究:基于血管外科学会2020年修订指南的手术指征评价
IF 0.6 Q4 PERIPHERAL VASCULAR DISEASE Pub Date : 2025-01-01 Epub Date: 2025-06-13 DOI: 10.3400/avd.oa.24-00128
Nozomu Ishikawa, Kazunori Inuzuka, Masaki Sano, Kazuto Katahashi, Hajime Tsuyuki, Yusuke Endo, Takaaki Saito, Hiroya Takeuchi, Naoki Unno

Objectives: Advancements in imaging technology have led to an increase in the incidental detection of visceral artery aneurysms (VAAs), which are associated with high mortality when ruptured. In 2020, the Society for Vascular Surgery (SVS) released updated guidelines, replacing the previous 2005 ACC/AHA recommendations. This study aimed to evaluate the impact of the new guidelines through a retrospective analysis of VAA cases treated at our department. Methods: We retrospectively reviewed 43 cases of VAA treated between 2002 and 2024 at our department. Each case was re-evaluated to determine whether it met the treatment criteria defined in the 2020 SVS guidelines. Results: Of the 43 cases, 23 (53.5%) met the new guideline criteria. Notably, treatment eligibility for renal and splenic artery aneurysms decreased significantly due to the revised aneurysm size threshold, raised from 2 to 3 cm. The remaining 20 cases were considered ineligible based solely on size, with the exception of cases involving young female patients, ruptured aneurysms, symptomatic lesions, or pseudoaneurysms. Conclusions: The 2020 SVS guidelines impose stricter treatment indications for VAAs. However, clinical decisions should also consider aneurysm location, patient age, gender, symptoms, and rupture risk on an individual basis.

目的:成像技术的进步导致意外发现内脏动脉瘤(VAAs)的增加,这与破裂后的高死亡率有关。2020年,血管外科学会(SVS)发布了更新的指南,取代了2005年ACC/AHA的建议。本研究旨在通过对我科治疗的VAA病例的回顾性分析来评估新指南的影响。方法:回顾性分析2002 ~ 2024年我科收治的43例VAA病例。对每个病例进行重新评估,以确定其是否符合2020年SVS指南中定义的治疗标准。结果:43例患者中,23例(53.5%)符合新指南标准。值得注意的是,由于动脉瘤大小阈值从2厘米提高到3厘米,肾和脾动脉瘤的治疗资格显著降低。除了年轻女性患者、动脉瘤破裂、症状性病变或假性动脉瘤外,其余20例仅根据大小被认为不合格。结论:2020年SVS指南对VAAs的治疗适应证提出了更严格的要求。然而,临床决定还应考虑动脉瘤位置、患者年龄、性别、症状和个体破裂风险。
{"title":"Retrospective Study of 43 Cases of Visceral Artery Aneurysms: Evaluation of Surgical Indications Based on the 2020 Revised Guidelines of the Society for Vascular Surgery.","authors":"Nozomu Ishikawa, Kazunori Inuzuka, Masaki Sano, Kazuto Katahashi, Hajime Tsuyuki, Yusuke Endo, Takaaki Saito, Hiroya Takeuchi, Naoki Unno","doi":"10.3400/avd.oa.24-00128","DOIUrl":"10.3400/avd.oa.24-00128","url":null,"abstract":"<p><p><b>Objectives:</b> Advancements in imaging technology have led to an increase in the incidental detection of visceral artery aneurysms (VAAs), which are associated with high mortality when ruptured. In 2020, the Society for Vascular Surgery (SVS) released updated guidelines, replacing the previous 2005 ACC/AHA recommendations. This study aimed to evaluate the impact of the new guidelines through a retrospective analysis of VAA cases treated at our department. <b>Methods:</b> We retrospectively reviewed 43 cases of VAA treated between 2002 and 2024 at our department. Each case was re-evaluated to determine whether it met the treatment criteria defined in the 2020 SVS guidelines. <b>Results:</b> Of the 43 cases, 23 (53.5%) met the new guideline criteria. Notably, treatment eligibility for renal and splenic artery aneurysms decreased significantly due to the revised aneurysm size threshold, raised from 2 to 3 cm. The remaining 20 cases were considered ineligible based solely on size, with the exception of cases involving young female patients, ruptured aneurysms, symptomatic lesions, or pseudoaneurysms. <b>Conclusions:</b> The 2020 SVS guidelines impose stricter treatment indications for VAAs. However, clinical decisions should also consider aneurysm location, patient age, gender, symptoms, and rupture risk on an individual basis.</p>","PeriodicalId":7995,"journal":{"name":"Annals of vascular diseases","volume":"18 1","pages":""},"PeriodicalIF":0.6,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12170097/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144309443","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Improvement of Gait Biomechanics after Endovascular Therapy for Patients with Intermittent Claudication Associated with Aortoiliac Occlusive Disease. 主动脉髂闭塞性间歇性跛行血管内治疗后步态生物力学的改善
IF 0.6 Q4 PERIPHERAL VASCULAR DISEASE Pub Date : 2025-01-01 Epub Date: 2025-06-10 DOI: 10.3400/avd.oa.25-00006
Norinobu Ogasawara, Takaaki Kakihana, Daijirou Akamatsu, Yuta Tajima, Michihisa Umetsu, Takanori Ishida, Michiaki Unno, Hitoshi Goto, Takashi Kamei, Masahiro Kohzuki

Objectives: Gait disturbances increase mortality rates in lower extremity artery disease. Changes in gait biomechanics after endovascular therapy for intermittent claudication associated with lower extremity artery disease remain unknown. This prospective study investigated the effect of endovascular therapy on gait biomechanics in intermittent claudication. Methods: We recruited 10 patients (14 affected limbs) with intermittent claudication caused by isolated aortoiliac artery lesions who underwent endovascular therapy, and 10 healthy controls. Using 3-dimensional motion analysis, we measured biomechanical gait parameters preoperatively and over 6 months postoperatively, comparing them with those of healthy controls. Results: One month after endovascular therapy, parameters improved significantly compared with preoperative values: step length (preoperative median 52.47 [interquartile range 47.11, 60.33]-postoperative 58.53 [54.63, 64.54] cm; P < 0.0037), walking speed (90.17 [73.98, 108.9]-103.49 [97.66, 117.94] cm/s; P = 0.0022), hip flexor moment (-0.75 [-1.04, -0.51] to -0.94 [-1.07, -0.74] Nm/kg; P = 0.04), and pull-off power generated by hip flexor muscles (H3, 0.68 [0.38, 1]-0.86 [0.72, 1.1] W/kg; P = 0.018). Preoperative joint power declined significantly compared to control parameters. However, 6 months postoperatively, no significant differences were observed. Conclusions: Endovascular therapy for isolated aortoiliac artery lesions improved biomechanical gait parameters in patients with intermittent claudication.

目的:步态障碍增加下肢动脉疾病的死亡率。对伴有下肢动脉疾病的间歇性跛行进行血管内治疗后步态生物力学的变化尚不清楚。本前瞻性研究探讨了血管内治疗对间歇性跛行患者步态生物力学的影响。方法:我们招募了10例(14条患肢)因孤立性主动脉髂动脉病变而行血管内治疗的间歇性跛行患者和10例健康对照。通过三维运动分析,我们测量了术前和术后6个月的生物力学步态参数,并与健康对照组进行了比较。结果:血管内治疗1个月后,各项参数较术前有明显改善:步长(术前中位数52.47[四分位数间距47.11,60.33]-术后58.53 [54.63,64.54]cm;P < 0.0037),行走速度(90.17 [73.98,108.9]-103.49 [97.66,117.94]cm/s;P = 0.0022),髋屈肌力矩(-0.75 [-1.04,-0.51]~ -0.94 [-1.07,-0.74]Nm/kg;P = 0.04),髋屈肌产生的拉离力(H3, 0.68 [0.38, 1]-0.86 [0.72, 1.1] W/kg;P = 0.018)。与对照参数相比,术前关节力量明显下降。然而,术后6个月,未观察到显著差异。结论:血管内治疗孤立主动脉髂动脉病变可改善间歇性跛行患者的生物力学步态参数。
{"title":"Improvement of Gait Biomechanics after Endovascular Therapy for Patients with Intermittent Claudication Associated with Aortoiliac Occlusive Disease.","authors":"Norinobu Ogasawara, Takaaki Kakihana, Daijirou Akamatsu, Yuta Tajima, Michihisa Umetsu, Takanori Ishida, Michiaki Unno, Hitoshi Goto, Takashi Kamei, Masahiro Kohzuki","doi":"10.3400/avd.oa.25-00006","DOIUrl":"10.3400/avd.oa.25-00006","url":null,"abstract":"<p><p><b>Objectives:</b> Gait disturbances increase mortality rates in lower extremity artery disease. Changes in gait biomechanics after endovascular therapy for intermittent claudication associated with lower extremity artery disease remain unknown. This prospective study investigated the effect of endovascular therapy on gait biomechanics in intermittent claudication. <b>Methods:</b> We recruited 10 patients (14 affected limbs) with intermittent claudication caused by isolated aortoiliac artery lesions who underwent endovascular therapy, and 10 healthy controls. Using 3-dimensional motion analysis, we measured biomechanical gait parameters preoperatively and over 6 months postoperatively, comparing them with those of healthy controls. <b>Results:</b> One month after endovascular therapy, parameters improved significantly compared with preoperative values: step length (preoperative median 52.47 [interquartile range 47.11, 60.33]-postoperative 58.53 [54.63, 64.54] cm; <i>P</i> < 0.0037), walking speed (90.17 [73.98, 108.9]-103.49 [97.66, 117.94] cm/s; <i>P</i> = 0.0022), hip flexor moment (-0.75 [-1.04, -0.51] to -0.94 [-1.07, -0.74] Nm/kg; <i>P</i> = 0.04), and pull-off power generated by hip flexor muscles (H3, 0.68 [0.38, 1]-0.86 [0.72, 1.1] W/kg; <i>P</i> = 0.018). Preoperative joint power declined significantly compared to control parameters. However, 6 months postoperatively, no significant differences were observed. <b>Conclusions:</b> Endovascular therapy for isolated aortoiliac artery lesions improved biomechanical gait parameters in patients with intermittent claudication.</p>","PeriodicalId":7995,"journal":{"name":"Annals of vascular diseases","volume":"18 1","pages":""},"PeriodicalIF":0.6,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12158554/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144274037","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Surgical Strategy of Intravenous Leiomyomatosis with Intracardiac Extension: A Case Report. 静脉平滑肌瘤病伴心内扩张的手术治疗策略1例。
IF 0.6 Q4 PERIPHERAL VASCULAR DISEASE Pub Date : 2025-01-01 Epub Date: 2025-08-28 DOI: 10.3400/avd.cr.25-00062
Shun Sato, Kazuo Yamanaka, Yuri Hashimura, Michiyuki Ichikawa, Yuichi Tara, Daisuke Nakatsuka, Takeshi Nishina

Intravenous leiomyomatosis with intracardiac extension is a rare benign tumor originating from uterine smooth muscle. A 50-year-old woman presented with a cardiac mass 3 years after hysterectomy. Imaging revealed a tumor extending from the right internal iliac vein to the right atrium. Complete resection was achieved via a 2-stage surgery. In the 1st stage, median sternotomy and a retroperitoneal approach were performed, and the intracardiac tumor was excised under deep hypothermic circulatory arrest with cardiopulmonary bypass. Postoperatively, gonadotropin-releasing hormone (GnRH) agonist therapy was administered, followed by a 2nd-stage resection of the residual pelvic tumor and right ovary. The patient remained recurrence-free for 15 months.

摘要静脉内平滑肌瘤病是一种罕见的良性肿瘤,起源于子宫平滑肌。一位50岁的女性在子宫切除术后3年出现心脏肿块。影像显示肿瘤从右髂内静脉延伸至右心房。通过两个阶段的手术实现了完全切除。第一阶段,行胸骨正中切口和腹膜后入路,在深低温循环停搏联合体外循环下切除心内肿瘤。术后给予促性腺激素释放激素(GnRH)激动剂治疗,第二阶段切除盆腔残余肿瘤和右侧卵巢。患者15个月无复发。
{"title":"Surgical Strategy of Intravenous Leiomyomatosis with Intracardiac Extension: A Case Report.","authors":"Shun Sato, Kazuo Yamanaka, Yuri Hashimura, Michiyuki Ichikawa, Yuichi Tara, Daisuke Nakatsuka, Takeshi Nishina","doi":"10.3400/avd.cr.25-00062","DOIUrl":"10.3400/avd.cr.25-00062","url":null,"abstract":"<p><p>Intravenous leiomyomatosis with intracardiac extension is a rare benign tumor originating from uterine smooth muscle. A 50-year-old woman presented with a cardiac mass 3 years after hysterectomy. Imaging revealed a tumor extending from the right internal iliac vein to the right atrium. Complete resection was achieved via a 2-stage surgery. In the 1st stage, median sternotomy and a retroperitoneal approach were performed, and the intracardiac tumor was excised under deep hypothermic circulatory arrest with cardiopulmonary bypass. Postoperatively, gonadotropin-releasing hormone (GnRH) agonist therapy was administered, followed by a 2nd-stage resection of the residual pelvic tumor and right ovary. The patient remained recurrence-free for 15 months.</p>","PeriodicalId":7995,"journal":{"name":"Annals of vascular diseases","volume":"18 1","pages":""},"PeriodicalIF":0.6,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12406148/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144999554","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Current Status of Diagnostic Process in Asymptomatic Abdominal Aortic Aneurysm in Japan. 日本无症状腹主动脉瘤的诊断现状
IF 0.6 Q4 PERIPHERAL VASCULAR DISEASE Pub Date : 2025-01-01 Epub Date: 2025-03-28 DOI: 10.3400/avd.oa.25-00025
Yoshimasa Seike, Nobuyoshi Azuma, Takao Ohki, Noriyasu Morikage, Akio Kodama, Makoto Sumi, Koji Maeda, Hitoshi Matsuda

Objectives: This study aimed to investigate the actual detection process and diagnostic methods for asymptomatic abdominal aortic aneurysm (AAA) in a multicenter setting, and to plan an effective screening strategy for asymptomatic AAA. Methods: The subjects of this multicenter study were collected in a retrospective manner at 7 facilities. A total of 1894 patients with AAA, including iliac artery aneurysms, who were considered asymptomatic with a confirmed initial diagnosis from January 2018 to December 2022, were collected and reviewed. Results: A total of 1666 patients who were diagnosed with asymptomatic AAA were included [83.9% males, median age of 75 (69-81) years]. Asymptomatic AAAs were frequently diagnosed during examinations for other diseases in 1339 patients (80.4%), whereas health screenings accounted for only 313 (18.8%). Computed tomography (CT) was the most commonly used diagnostic method (n = 1352, 81.2%) compared to abdominal ultrasonography (n = 252, 15.2%). Conclusions: Asymptomatic AAAs are detected incidentally during examinations for other diseases, and there is an urgent need to promote health screening. Most AAAs are diagnosed by CT; nevertheless, we consider that abdominal ultrasonography would be the most appropriate modality for AAA screening because of its reasonable accuracy, noninvasiveness, and low cost.

目的:本研究旨在探讨无症状腹主动脉瘤(AAA)在多中心环境下的实际检测过程和诊断方法,制定有效的无症状腹主动脉瘤筛查策略。方法:本多中心研究回顾性收集7家机构的受试者。从2018年1月至2022年12月,共收集并回顾了1894例经初步确诊为无症状的AAA患者,包括髂动脉动脉瘤。结果:共纳入无症状AAA患者1666例[男性83.9%,中位年龄75(69 ~ 81)岁]。1339例(80.4%)患者在其他疾病检查中经常被诊断为无症状AAAs,而健康筛查仅占313例(18.8%)。计算机断层扫描(CT)是最常用的诊断方法(n = 1352, 81.2%),腹部超声检查(n = 252, 15.2%)。结论:无症状AAAs是在其他疾病检查中偶然发现的,迫切需要加强健康筛查。大多数AAAs是通过CT诊断的;尽管如此,我们认为腹部超声检查将是最合适的AAA筛查方式,因为它具有合理的准确性、无创性和低成本。
{"title":"Current Status of Diagnostic Process in Asymptomatic Abdominal Aortic Aneurysm in Japan.","authors":"Yoshimasa Seike, Nobuyoshi Azuma, Takao Ohki, Noriyasu Morikage, Akio Kodama, Makoto Sumi, Koji Maeda, Hitoshi Matsuda","doi":"10.3400/avd.oa.25-00025","DOIUrl":"10.3400/avd.oa.25-00025","url":null,"abstract":"<p><p><b>Objectives:</b> This study aimed to investigate the actual detection process and diagnostic methods for asymptomatic abdominal aortic aneurysm (AAA) in a multicenter setting, and to plan an effective screening strategy for asymptomatic AAA. <b>Methods:</b> The subjects of this multicenter study were collected in a retrospective manner at 7 facilities. A total of 1894 patients with AAA, including iliac artery aneurysms, who were considered asymptomatic with a confirmed initial diagnosis from January 2018 to December 2022, were collected and reviewed. <b>Results:</b> A total of 1666 patients who were diagnosed with asymptomatic AAA were included [83.9% males, median age of 75 (69-81) years]. Asymptomatic AAAs were frequently diagnosed during examinations for other diseases in 1339 patients (80.4%), whereas health screenings accounted for only 313 (18.8%). Computed tomography (CT) was the most commonly used diagnostic method (n = 1352, 81.2%) compared to abdominal ultrasonography (n = 252, 15.2%). <b>Conclusions:</b> Asymptomatic AAAs are detected incidentally during examinations for other diseases, and there is an urgent need to promote health screening. Most AAAs are diagnosed by CT; nevertheless, we consider that abdominal ultrasonography would be the most appropriate modality for AAA screening because of its reasonable accuracy, noninvasiveness, and low cost.</p>","PeriodicalId":7995,"journal":{"name":"Annals of vascular diseases","volume":"18 1","pages":""},"PeriodicalIF":0.6,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11957909/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143750786","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Risk Factors for Acute Hemorrhagic Rectal Ulcers after Bypass Surgery for Chronic Limb-Threatening Ischemia. 慢性肢体缺血旁路手术后急性出血性直肠溃疡的危险因素。
IF 0.6 Q4 PERIPHERAL VASCULAR DISEASE Pub Date : 2025-01-01 Epub Date: 2025-04-01 DOI: 10.3400/avd.oa.24-00125
Yohei Kawai, Masayuki Sugimoto, Takuya Osawa, Changi Lee, Shuta Ikeda, Kiyoaki Niimi, Hiroshi Banno

Objectives: Acute hemorrhagic rectal ulcer (AHRU) occurs with a sudden onset of painless bloody stools and is caused by impaired blood flow in the rectal mucosa due to arteriosclerosis or prolonged bedridden status. Little information is available about AHRU in patients with chronic limb-threatening ischemia (CLTI). This study aimed to identify factors related to AHRU among CLTI patients after bypass surgery. Methods: Between 2019 and 2023, we enrolled 80 CLTI patients at our institution who underwent bypass surgery using autogenous veins. Data were collected prospectively and supplemented with retrospective medical record reviews. Information regarding demographic and clinical characteristics was collected. The outcomes of patients without AHRU (non-AHRU group) and those with AHRU (AHRU group) were compared. Logistic regression analysis was used to assess factors associated with AHRU after bypass surgery. Results: During the study period, 6 of the 80 patients (7.5%) experienced AHRU after bypass surgery. There was no significant difference in the global limb anatomic staging system (GLASS) or wound ischemia and foot infection (WIfI) stage between the 2 groups. The percentage of patients taking oral steroids was significantly greater in the AHRU group. In addition, the AHRU group had a significantly greater percentage of postoperative ambulatory failure and a longer hospital stay. In the univariate analysis of factors associated with the incidence of AHRU after bypass surgery, steroid use (odds ratio [OR], 13.8; 95% confidence interval [CI], 2.19-86.9; P = 0.005) and nonambulatory status after surgery (OR, 7.22; 95% CI, 1.26-41.4; P = 0.026) were significant factors. Conclusions: Steroid use and postoperative nonambulatory status were associated with AHRU after bypass surgery for CLTI.

目的:急性出血性直肠溃疡(AHRU)是由动脉硬化或长期卧床引起的直肠粘膜血流受损引起的,发病时伴有无痛性带血便。关于慢性肢体威胁缺血(CLTI)患者AHRU的信息很少。本研究旨在确定搭桥术后CLTI患者AHRU的相关因素。方法:在2019年至2023年期间,我们在我们的机构招募了80例使用自体静脉进行搭桥手术的CLTI患者。前瞻性收集数据,并辅以回顾性病历回顾。收集有关人口统计学和临床特征的信息。比较无AHRU患者(非AHRU组)和有AHRU患者(AHRU组)的预后。采用Logistic回归分析评估搭桥术后AHRU相关因素。结果:在研究期间,80例患者中有6例(7.5%)发生搭桥术后AHRU。两组患者整体肢体解剖分期系统(GLASS)、创面缺血及足部感染(WIfI)分期差异无统计学意义。服用口服类固醇的患者比例在AHRU组中明显更高。此外,AHRU组术后动态失败的比例明显更高,住院时间也更长。在与搭桥术后AHRU发生率相关因素的单因素分析中,类固醇使用(优势比[OR], 13.8;95%置信区间[CI], 2.19-86.9;P = 0.005)和术后非活动状态(OR, 7.22;95% ci, 1.26-41.4;P = 0.026)为显著因素。结论:类固醇使用和术后非活动状态与CLTI搭桥术后AHRU相关。
{"title":"Risk Factors for Acute Hemorrhagic Rectal Ulcers after Bypass Surgery for Chronic Limb-Threatening Ischemia.","authors":"Yohei Kawai, Masayuki Sugimoto, Takuya Osawa, Changi Lee, Shuta Ikeda, Kiyoaki Niimi, Hiroshi Banno","doi":"10.3400/avd.oa.24-00125","DOIUrl":"10.3400/avd.oa.24-00125","url":null,"abstract":"<p><p><b>Objectives:</b> Acute hemorrhagic rectal ulcer (AHRU) occurs with a sudden onset of painless bloody stools and is caused by impaired blood flow in the rectal mucosa due to arteriosclerosis or prolonged bedridden status. Little information is available about AHRU in patients with chronic limb-threatening ischemia (CLTI). This study aimed to identify factors related to AHRU among CLTI patients after bypass surgery. <b>Methods:</b> Between 2019 and 2023, we enrolled 80 CLTI patients at our institution who underwent bypass surgery using autogenous veins. Data were collected prospectively and supplemented with retrospective medical record reviews. Information regarding demographic and clinical characteristics was collected. The outcomes of patients without AHRU (non-AHRU group) and those with AHRU (AHRU group) were compared. Logistic regression analysis was used to assess factors associated with AHRU after bypass surgery. <b>Results:</b> During the study period, 6 of the 80 patients (7.5%) experienced AHRU after bypass surgery. There was no significant difference in the global limb anatomic staging system (GLASS) or wound ischemia and foot infection (WIfI) stage between the 2 groups. The percentage of patients taking oral steroids was significantly greater in the AHRU group. In addition, the AHRU group had a significantly greater percentage of postoperative ambulatory failure and a longer hospital stay. In the univariate analysis of factors associated with the incidence of AHRU after bypass surgery, steroid use (odds ratio [OR], 13.8; 95% confidence interval [CI], 2.19-86.9; P = 0.005) and nonambulatory status after surgery (OR, 7.22; 95% CI, 1.26-41.4; P = 0.026) were significant factors. <b>Conclusions:</b> Steroid use and postoperative nonambulatory status were associated with AHRU after bypass surgery for CLTI.</p>","PeriodicalId":7995,"journal":{"name":"Annals of vascular diseases","volume":"18 1","pages":""},"PeriodicalIF":0.6,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11964780/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143770949","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Acute Inflammatory Pseudoaneurysm of the Gastroepiploic Artery in a Patient with Multiple Aneurysms: A Case Highlighting Systemic Vascular Remodeling. 多发性动脉瘤患者胃网膜动脉急性炎性假性动脉瘤:一例系统性血管重构。
IF 0.6 Q4 PERIPHERAL VASCULAR DISEASE Pub Date : 2025-01-01 Epub Date: 2025-08-20 DOI: 10.3400/avd.cr.25-00072
Yuri Yoshida, Shinsuke Kikuchi, Daiki Uchida, Naoya Kuriyama, Yuki Tada, Atsuhiro Koya, Sayaka Yuzawa, Hisashi Uchida, Mishie Tanino, Nobuyoshi Azuma

A 52-year-old man with scoliosis and psoriasis vulgaris, treated with infliximab, presented with a large right gastroepiploic artery aneurysm (GEAA). Following surgical resection, additional aneurysms of the anterior communicating artery and abdominal aorta were identified. Histopathological examination revealed a pseudoaneurysm with organizing thrombus and marked acute inflammation, including neutrophilic infiltration of the medial wall. Despite negative cultures, an infection-related vascular insult could not be excluded. This case highlights a rare immune-mediated vascular pathology in the context of chronic inflammatory disease, emphasizing the potential role of acute inflammation and psoriasis-associated immune dysregulation in visceral artery aneurysm formation.

52岁男性脊柱侧凸伴寻常型银屑病,接受英夫利昔单抗治疗,表现为右侧大胃网膜动脉瘤(GEAA)。手术切除后,发现了前交通动脉和腹主动脉的其他动脉瘤。组织病理学检查显示假性动脉瘤伴组织血栓和明显的急性炎症,包括内侧壁中性粒细胞浸润。尽管培养阴性,但不能排除感染相关的血管损伤。本病例强调了慢性炎症性疾病中罕见的免疫介导的血管病理,强调了急性炎症和银屑病相关免疫失调在内脏动脉瘤形成中的潜在作用。
{"title":"Acute Inflammatory Pseudoaneurysm of the Gastroepiploic Artery in a Patient with Multiple Aneurysms: A Case Highlighting Systemic Vascular Remodeling.","authors":"Yuri Yoshida, Shinsuke Kikuchi, Daiki Uchida, Naoya Kuriyama, Yuki Tada, Atsuhiro Koya, Sayaka Yuzawa, Hisashi Uchida, Mishie Tanino, Nobuyoshi Azuma","doi":"10.3400/avd.cr.25-00072","DOIUrl":"10.3400/avd.cr.25-00072","url":null,"abstract":"<p><p>A 52-year-old man with scoliosis and psoriasis vulgaris, treated with infliximab, presented with a large right gastroepiploic artery aneurysm (GEAA). Following surgical resection, additional aneurysms of the anterior communicating artery and abdominal aorta were identified. Histopathological examination revealed a pseudoaneurysm with organizing thrombus and marked acute inflammation, including neutrophilic infiltration of the medial wall. Despite negative cultures, an infection-related vascular insult could not be excluded. This case highlights a rare immune-mediated vascular pathology in the context of chronic inflammatory disease, emphasizing the potential role of acute inflammation and psoriasis-associated immune dysregulation in visceral artery aneurysm formation.</p>","PeriodicalId":7995,"journal":{"name":"Annals of vascular diseases","volume":"18 1","pages":""},"PeriodicalIF":0.6,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12375504/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144939377","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Annals of vascular diseases
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1